A pilot study of a smoking cessation intervention for women living with HIV: study protocol
Received 3 November 2016
Accepted for publication 21 December 2016
Published 7 February 2017 Volume 2017:9 Pages 11—20
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Professor Greg Martin
Sun S Kim, Sabreen Darwish, Sang A Lee, Rosanna F DeMarco
Department of Nursing, College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, USA
Background: Prevalence of cigarette smoking is substantially higher among people living with human immunodeficiency virus (HIV) than the general population in the USA. Women living with HIV (WLHIV) who smoke are at higher risk of developing acquired immunodeficiency syndrome and have a higher mortality rate than nonsmoking WLHIV. Compared to men, women generally require more intensive counseling for smoking cessation. The primary aim of this study is to examine the acceptability and feasibility of a videoconferencing smoking cessation intervention that is tailored to the specific needs of WLHIV.
Methods: A total of 50 WLHIV will be randomized at a ratio of 1:1 to either a videoconferencing or a telephone counseling arm. Both arms have the same cessation intervention, that is, eight weekly individualized counseling sessions of 30-minute cognitive behavioral therapy plus active nicotine patches for 8 weeks. The only difference between the two arms is the delivery mode of the counseling, that is, telephone video call vs. telephone voice call. Data collection is scheduled at baseline and three follow-up points: 1, 3, and 6 months from the target quit day. Data will be analyzed using STATA 14. The primary outcome is a 6-month prolonged abstinence. Home-based salivary cotinine test will be conducted to verify self-reported smoking abstinence using a NicAlert® test strip, while a research coordinator monitors the whole process by a telephone video call.
Conclusion: The study is a two-arm parallel-group pilot clinical trial of a smoking cessation intervention. It attempts to examine whether videoconferencing smoking cessation intervention will be acceptable and feasible for WLHIV and will yield a better cessation outcome than telephone counseling intervention. Findings may have the potential to identify effective intervention strategies that will reduce and eliminate health disparities in tobacco control among WLHIV.
Keywords: HIV, women, smoking cessation, videoconferencing, biochemical validation
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Other article by this author:
A randomized controlled trial of a videoconferencing smoking cessation intervention for Korean American women: preliminary findings
Kim SS, Sitthisongkram S, Bernstein K, Fang H, Choi WS, Ziedonis D
Published Date: 7 September 2016